{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:44:48Z","timestamp":1793256288341,"version":"4.5.0"},"reference-count":123,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1586\/14787210.1.4.597","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T08:40:53Z","timestamp":1105605653000},"page":"597-608","source":"Crossref","is-referenced-by-count":17,"title":["Pathogenesis of Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1586","volume":"1","author":[{"given":"Raymond SW","family":"Tsang","sequence":"first","affiliation":[{"name":"CNS Infection and Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Health Canada, 1015 Arlington Street, Winnipeg, Manitoba, R3E 3R2, USA. rtsang@hc-sc.gc.ca"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Valdivieso-Garcia","sequence":"additional","affiliation":[{"name":"Laboratory for Foodborne Zoonoses, Health Canada, 110 Stone Road West, Guelph, Ontario, N1G 3W4, USA. alfonso_valdivieso@hc-sc.gc.ca"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"e_1_2_1_5_1","first-page":"1462","article-title":"Sur un syndrome de radioculo-nevrite avec huyperalbuminose du liquide cephalorachidien sans reaction cellulaire: Remarques sur les caracters cliniques et graphiques des reflexes tendineux","volume":"40","author":"Guillain G","year":"1916","unstructured":"Guillain G, Barre JA, Strohl A. Sur un syndrome de radioculo-nevrite avec huyperalbuminose du liquide cephalorachidien sans reaction cellulaire: Remarques sur les caracters cliniques et graphiques des reflexes tendineux. Bull. Soc. Med. Hop. Paris 40,1462\u20131470 (1916).","journal-title":"Bull. Soc. Med. Hop. Paris"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270707"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00812150"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","unstructured":"Asbury AK. New concepts of Guillain\u2014Barre syndrome.\/ Child NeuroL15 183\u2013191 (2000).","DOI":"10.1177\/088307380001500308"},{"key":"e_1_2_1_9_1","unstructured":"\u2022Provides a good summary of the clinical aspects and pathology of GBS subtypes."},{"key":"e_1_2_1_10_1","unstructured":"Ad Hov Committee WHO-AIREN. Acute onset flaccid paralysis. World Health Organization Geneva Switzerland (1993)."},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410410302"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000052111"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.9.3346-3349.2001"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","unstructured":"Yuki N. Infectious origins of and molecular mimicry in Guillain\u2014Barre and Fisher syndromes. Lancet Infect. Dis. 1 29\u201337 (2001).","DOI":"10.1016\/S1473-3099(01)00019-6"},{"key":"e_1_2_1_15_1","unstructured":"\u2022\u2022A comprehensive review on current viewsof infections related to GBS with diagratntnatical explanation of the pathogenic mechanisms with emphasis on the Fisher syndrome."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.4.1110"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","unstructured":"Hadden RD Karch H Hartung HP Preceding infections immune factors and outcome in Guillain\u2014Barre syndrome. Neurology 56 758-765 (2001).seThis large multicenter study involvingpatients from 11 countries described preceding infections antibodies togangliosides adhesion molecules cytokine receptors and clinical features associated with GBS.","DOI":"10.1212\/WNL.56.6.758"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200206000-00002"},{"key":"e_1_2_1_19_1","first-page":"668","article-title":". Cytomegalovirus infection and Guillain\u2014Barre syndrome: the clinical, electrophysiological and prognostic features, Dutch Guillain\u2014Barre Study Group","volume":"47","author":"Visser LH","year":"1996","unstructured":"Visser LH, Van der Meche FG, Meulstee J, et al . Cytomegalovirus infection and Guillain\u2014Barre syndrome: the clinical, electrophysiological and prognostic features, Dutch Guillain\u2014Barre Study Group. Neural. 47,668\u2013673 (1996).","journal-title":"Neural"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/118.3.577"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.1.33"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-196905000-00001"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400414"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-4310(99)01639-1"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/268752a0"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830220721"},{"key":"e_1_2_1_28_1","first-page":"587","article-title":"ME. Experimental autoimmune peripheral neuritis induced in Balb\/c mice by myelin basic protein-specific T-cell clones","volume":"182","author":"Abromson-Leeman S","year":"1995","unstructured":"Abromson-Leeman S, Bronson R, Dorf ME. Experimental autoimmune peripheral neuritis induced in Balb\/c mice by myelin basic protein-specific T-cell clones. J. Bcp. Med 182, 587\u2013592 (1995).","journal-title":"J. Bcp. Med"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/121.10.1895"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(99)00004-1"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410190109"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(00)00045-9"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.21.1.187"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(01)00580-9"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.4.610"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.6.3896"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.2000.0490"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.4.736"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1012"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199902)45:2<189::AID-ANA9>3.0.CO;2-T"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200006)47:6<765::AID-ANA9>3.0.CO;2-8"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.8.1096"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204233261705"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1057"},{"key":"e_1_2_1_45_1","unstructured":"\u2022\u2022Summarizes recent findings on GBS andAMAN that fulfil requirements to satisfy Koch's postulates for the pathogenesis of GBS."},{"key":"e_1_2_1_46_1","first-page":"234","article-title":"Antiglycolipid antibodies in Guillain\u2014Barre syndrome and autoimmune neuropathies","volume":"319","author":"Kusunoki S","year":"2000","unstructured":"Kusunoki S. Antiglycolipid antibodies in Guillain\u2014Barre syndrome and autoimmune neuropathies. Am. J. Med. Sci. 319, 234\u2013239 (2000).","journal-title":"Am. J. Med. Sci"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410310619"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.2.204"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10060"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200003)47:3<314::AID-ANA6>3.0.CO;2-C"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.6.767"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880150806"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199906)45:6<758::AID-ANA10>3.0.CO;2-N"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg030"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.3.1202-1208.2002"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(96)01123-7"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.5.893"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.6.1282"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(92)90069-W"},{"key":"e_1_2_1_61_1","first-page":"262","article-title":"Campylobacter DNA is present in circulating myelomonocytic cells of healthy persons and in persons with Guillain\u2014Barre syndrome.\"","volume":"185","author":"Van Rhijn I","year":"2002","unstructured":"Van Rhijn I, Bleumink-Pluym NM, VanPutten JP Van den Berg LH. Campylobacter DNA is present in circulating myelomonocytic cells of healthy persons and in persons with Guillain\u2014Barre syndrome.\"Dis. 185,262\u2013265 (2002).","journal-title":"Dis"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.69.4.522"},{"key":"e_1_2_1_63_1","unstructured":"\u2022Demonstrates a possible link exists between gastroenteric infections and development of neurological disease by demonstrating the presence of y8 T-cells which are normally found in theintestines are also found in a sural nerve biopsy taken from a GBS patient."},{"key":"e_1_2_1_64_1","first-page":"115","article-title":"Immunoglobulin G subclass distribution and autoantibodies to gangliosides in patients with Guillain\u2014Barre syndrome","volume":"109","author":"Ilyas AA","year":"2001","unstructured":"Ilyas AA, Chen ZW, Cook SD, Mithen FA, Singhal BS. Immunoglobulin G subclass distribution and autoantibodies to gangliosides in patients with Guillain\u2014Barre syndrome. Res. Commun. Mot Pathol Pharmacol 109,115\u2013123 (2001).","journal-title":"Res. Commun. Mot Pathol Pharmacol"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7542404"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(98)00121-X"},{"key":"e_1_2_1_67_1","first-page":"1946","article-title":"A permanent rat T-cell line that mediates experimental allergic neuritis in the Lewis rat","volume":"133","author":"Linington C","year":"1984","unstructured":"Linington C, Izumo S, Suzuki M, UyemuraK Meyermann R Wekerle H. A permanent rat T-cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. j Immund 133,1946\u20131950 (1984).","journal-title":"in vivo. j Immund"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(87)90014-2"},{"key":"e_1_2_1_69_1","first-page":"3768","article-title":"Prevention and therapy of experimental autoimmune neuritis by an antibody against T-cell receptor-a\/I3","volume":"148","author":"Jung S","year":"1992","unstructured":"Jung S, Kramer S, Schluesener HJ, Hunig T,Toyka K, Hartung HP Prevention and therapy of experimental autoimmune neuritis by an antibody against T-cell receptor-a\/I3 Immund 148,3768\u20133775 (1992).","journal-title":"Immund"},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)90014-0"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(01)00241-7"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2002.7944"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200210000-00008"},{"key":"e_1_2_1_74_1","unstructured":"\u2022\u2022The immunopathogenic mechanisms indemylinating neuropathy is succinctly presented."},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(02)00393-4"},{"key":"e_1_2_1_76_1","unstructured":"\u2022A well-designed investigation that tracked down the levels of monocytic chemoattractant protein 1 and its receptor during the clinical progress of GBS."},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf070"},{"key":"e_1_2_1_78_1","unstructured":"\u2022In this investigation the expression patterns of specific chemokine and chemokine receptors in sural nerve biopsies from GBS patients were described induding the pathogenic role of specific chemokine receptor and cytokine."},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(99)00100-9"},{"key":"e_1_2_1_80_1","first-page":"887","article-title":"Inflammatory cytokines in the nervous system: multifunctional mediators in autoimmunity and cerebral ischaemia","volume":"158","author":"Stoll G","year":"2002","unstructured":"Stoll G. Inflammatory cytokines in the nervous system: multifunctional mediators in autoimmunity and cerebral ischaemia. Rev. Neural 158,887\u2013891 (2002).","journal-title":"Rev. Neural"},{"key":"e_1_2_1_81_1","unstructured":"\u2022\u2022An Excellent review on the effects ofcytokines in immune-mediated demyelination."},{"key":"e_1_2_1_82_1","unstructured":"Mossman TR Fowell DJ. The Th1\/Th2paradigm in infections. In: Immunology and Infectious Disease. Kaufmann SHE Sher A Ahmed R (Eds). ASM Press London UK 163\u2013174 (2002)."},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(00)00460-4"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10443"},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/61.7.614"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1997.4356"},{"key":"e_1_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2000.00636.x"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2002.tb00459.x"},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(00)00388-X"},{"key":"e_1_2_1_90_1","unstructured":"\u2022This study did not find elevated levels of IFN-y in GBS patients which is in contrast with EAN where activity of IFN-y has been dearly demonstrated."},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(02)00359-4"},{"issue":"1","key":"e_1_2_1_92_1","volume":"160","author":"Kurek JB","year":"1998","unstructured":"Kurek JB, Radford AJ, Crump DE, et al LIF (AI\\4424), a promising growth factor for the treatment of ALS. J. Neural Sci. 160\\(Suppl. 1), S106\u2014S113 (1998).","journal-title":"J. Neural Sci"},{"key":"e_1_2_1_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420112"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-9961(02)00007-4"},{"key":"e_1_2_1_95_1","first-page":"3301","article-title":"Jr. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of 1 icBcc: a mechanism for NF-ic B activation","volume":"13","author":"Beg AA","year":"1993","unstructured":"Beg AA, Finco TS, Nantermet PV, Baldwin AS Jr. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of 1 icBcc: a mechanism for NF-ic B activation. Mot Cell. Bial 13, 3301\u20133310 (1993).","journal-title":"Mot Cell. Bial"},{"key":"e_1_2_1_96_1","first-page":"1541","article-title":"IFN-a-inducing factor (IGIF) is a costimulatory factor on the activation of Thl but not Th2 cells and exerts its effect independently of IL-12","volume":"158","author":"Kohno K","year":"1997","unstructured":"Kohno K, Kataoka J, Ohtsuki T, et al. IFN-a-inducing factor (IGIF) is a costimulatory factor on the activation of Thl but not Th2 cells and exerts its effect independently of IL-12.j Immunot 158, 1541\u20131550 (1997).","journal-title":"j Immunot"},{"key":"e_1_2_1_97_1","first-page":"1096","article-title":"IL-18 is produced by articular chondrocytes and induces pro-inflammatory and catabolic responses","volume":"162","author":"Olee T","year":"1999","unstructured":"Olee T, Hashimoto S, Quach J, Lotz M. IL-18 is produced by articular chondrocytes and induces pro-inflammatory and catabolic responses. J. Immunot 162, 1096\u20131100 (1999).","journal-title":"J. Immunot"},{"key":"e_1_2_1_98_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/61.7.614"},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60387-9"},{"key":"e_1_2_1_100_1","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1998.0259"},{"key":"e_1_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1997.4331"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(97)00238-5"},{"key":"e_1_2_1_103_1","unstructured":"\u2022\u2022Summarizes the complexity of thecytokine network that is important in both GBS and EAN."},{"key":"e_1_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61665-3"},{"key":"e_1_2_1_105_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200110000-00009"},{"key":"e_1_2_1_106_1","unstructured":"\u2022Various aspects of GBS epidemiology was described including effect of sex age and preceding events."},{"key":"e_1_2_1_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(00)00369-6"},{"key":"e_1_2_1_108_1","unstructured":"\u2022An interesting paper that showed striking differences in the immune responses of different family members towards a family outbreak of Campylobacter jejuni enteritis."},{"issue":"2","key":"e_1_2_1_109_1","volume":"176","author":"Hughes RA","year":"1997","unstructured":"Hughes RA, Rees JH. Clinical and epidemiological features of Guillain\u2014Barre syndrome. J. Infect. Dis. 176\\(Suppl. 2), S92\u2014S98 (1997).","journal-title":"J. Infect. Dis"},{"key":"e_1_2_1_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(01)00395-2"},{"key":"e_1_2_1_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(98)00072-1"},{"key":"e_1_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(95)00102-8"},{"key":"e_1_2_1_113_1","first-page":"3074","article-title":"Differential distribution of HLA-DQ I3\/DR beta epitopes in the two forms of Guillain\u2014Barre syndrome, acute motor axonal neuropathy and acute inflammatory demyelinatingpolyneuropathy (AIDP): identification of DQ 13 epitopes associated with susceptibility to and protection from AIDPJ","volume":"170","author":"Magira EE","year":"2003","unstructured":"Magira EE, Papaiakim M, Nachamkin I, et al. Differential distribution of HLA-DQ I3\/DR beta epitopes in the two forms of Guillain\u2014Barre syndrome, acute motor axonal neuropathy and acute inflammatory demyelinatingpolyneuropathy (AIDP): identification of DQ 13 epitopes associated with susceptibility to and protection from AIDPJ Immunot 170,3074\u20133080 (2003).","journal-title":"Immunot"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.8.1661"},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09095-2"},{"key":"e_1_2_1_116_1","first-page":"586","volume":"341","author":"Guillain\u2014Barre Syndrome Steroid Therapy Group","year":"1993","unstructured":"Guillain\u2014Barre Syndrome Steroid Therapy Group. Double-blind trail of intravenous methylprednisolone in Guillain\u2014Barre syndrome. Lancet 341,586\u2013590 (1993).","journal-title":"Lancet"},{"key":"e_1_2_1_117_1","first-page":"586","author":"van Koningsveld RM","year":"2001","unstructured":"van Koningsveld RM, Schmitz PI, van Doom PA. Combined therapy of intravenous immune globulin and methylprednisolone in patients with Guillain\u2014Barre Syndrome. The results of a multicentre double-blind controlled clinical trial. J. Peripher. Nerv. Syst. 41, 586\u2013590 (2001) (Abstract).","journal-title":"J. Peripher. Nerv. Syst"},{"key":"e_1_2_1_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4886(85)90129-3"},{"key":"e_1_2_1_119_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.12_suppl_6.S13"},{"key":"e_1_2_1_120_1","unstructured":"\u2022\u2022A comprehensive review on the potentialmechanisms of intravenous immunoglobulin therapy for the treatment of neuropathies."},{"key":"e_1_2_1_121_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10205"},{"key":"e_1_2_1_122_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2002.00466.x"},{"key":"e_1_2_1_123_1","doi-asserted-by":"publisher","DOI":"10.1159\/000050777"},{"key":"e_1_2_1_124_1","doi-asserted-by":"publisher","DOI":"10.1159\/000050798"},{"key":"e_1_2_1_125_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.5.774"},{"key":"e_1_2_1_126_1","first-page":"279","article-title":"Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1\/Th2 balance and inhibited migration of inflammatory cells in the peripheral nerve tissue. Neuropharmacology 42,731-739 (2002).Ho Li CY, Xue P, Tian WQ, Liu RC, Yang C. Experimental Campylobacter jtjuni infection in the chicken: an animal model of axonal Guillain\u2014Barre syndrome","volume":"61","author":"Zou LP","year":"1996","unstructured":"Zou LP, Abbas N, Volkmann I, et al Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1\/Th2 balance and inhibited migration of inflammatory cells in the peripheral nerve tissue. Neuropharmacology 42,731-739 (2002).Ho Li CY, Xue P, Tian WQ, Liu RC, Yang C. Experimental Campylobacter jtjuni infection in the chicken: an animal model of axonal Guillain\u2014Barre syndrome. J. Neural Neurosurg. Psychiatry 61,279\u2013284 (1996).","journal-title":"J. Neural Neurosurg. Psychiatry"},{"key":"e_1_2_1_127_1","unstructured":"\u2022The chicken model described in this report may be the only animal model of GBS induced by Campylobacter jduni however there has not been other reports that confirmed this finding."}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14787210.1.4.597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:07:31Z","timestamp":1770415651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14787210.1.4.597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":123,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.1586\/14787210.1.4.597"],"URL":"https:\/\/doi.org\/10.1586\/14787210.1.4.597","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}